Vaccines continue to show remarkable effectiveness in preventing severe outcomes, even as breakthrough infections occur. Factors such as waning immunity and the aggressive nature of the delta variant may contribute to these cases, particularly among those with comorbidities or who were vaccinated early. Discussions around booster doses are gaining traction as a means to enhance protection, especially for vulnerable populations.
